An open-label phase IIa trial evaluating the safety and efficacy of EPO906 [patupilone] as therapy in patients with advanced breast cancer.
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Patupilone (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Feb 2017 Status changed from suspended to completed.
- 17 Sep 2005 New trial record.